Navigation Links
New Drug Found To Improve Driving Performance In Young Adults With ADHD

A new drug, ADDERALL XR? has been found to improve driving performance, cognitive function and attention in young adults with attention-deficit/hyperactivity disorder (ADHD).//

The result has been presented at the 18th Annual U.S. Psychiatric & Mental Health Congress in Las Vegas, NV and establishes that the drug helps young adults improve their ability to drive over a 12-hour period.

Accidents are the leading cause of death until age 40, the incidence of which is greater among adults with ADHD. Furthermore, the incidence of traffic violations and license suspensions is much greater than among patients with ADHD.

Infact, ADHD patients were five times more likely to have speeding tickets (5 or more) and three times more likely to succumb to vehicular clashes (thrice or more). This observation could be because of the fact that adolescent and adult patients often fail to appreciate the effect that ADHD symptoms such as inattention have on daily activities such as driving.

The researchers hence studied the effect of ADDERALL XR, a major ADHD therapy, on driving performance in young adult patients with ADHD. Participants received doses of ADDERALL XR at 20 milligrams (mg) for the first week and then increased to 40 mg and 50 mg for the second and third weeks, respectively.

All patients were evaluated for driving performance after the medication was administered. The STISIM was used to analyze the critical driving skills, including situation awareness, hazard perception, risk assessment and decision-making under time pressure.

Patients taking the drug demonstrated significant improvement in driving safety and performance compared to a placebo. Safety-related driving parameters, including speeding tickets, traffic tickets, crashes, crash avoidance rating, time to collision and excess speed were some of the factors taken into consideration during the assessment.

Furthermore, ADDERALL XR significantl y improved ADHD symptom control in young adults with ADHD as compared to those on placebo. Eighty percent of patients experienced at least a 30 percent reduction in their ADHD symptoms. It also had significant effects on the participants' attention, an important cognitive ability.

The majority of side effects during the trial were mild or moderate and consistent with known side effects of stimulant medications such as decreased appetite, weight loss, dry mouth, insomnia and bruxism (teeth grinding). These findings suggest that there is a carryover beneficial effect of having performed a mentally demanding task like driving. The effect would even be valuable when the individual is not taking the medication.
'"/>




Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, the ... by Walgreens and pharmacy benefit manager Prime Therapeutics LLC ... brand, which included the unveiling of new signage at ... as well as at a few other company-owned facilities ... brand to patients, some of whom will begin to ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
Breaking Medicine Technology: